News:

This week IPhone 15 Pro winner is karn
You can be too a winner! Become the top poster of the week and win valuable prizes.  More details are You are not allowed to view links. Register or Login 

Main Menu

FDA approves Roche diagnostic for gene mutation in lung cancer

Started by riky, May 15, 2013, 09:00:21 AM

Previous topic - Next topic

0 Members and 1 Guest are viewing this topic.

riky

FDA approves Roche diagnostic for gene mutation in lung cancer

<p><a href="http://news.yahoo.com/fda-approves-roche-diagnostic-gene-mutation-lung-cancer-211300633.html"><img src="http://l.yimg.com/bt/api/res/1.2/pPKR.l6qH70z.grkOLFC9Q--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2013-05-14T211300Z_1_CBRE94D1MXT00_RTROPTP_2_ROCHE.JPG" width="130" height="86" alt="Logo of Swiss pharmaceutical company Roche is pictured in Rotkreuz" align="left" title="Logo of Swiss pharmaceutical company Roche is pictured in Rotkreuz" border="0" /></a>(Reuters) - U.S. health regulators on Tuesday approved a test developed by Roche for a specific gene mutation present in about 10 percent of non-small cell lung cancers, and said the company's drug Tarceva could be used as an initial treatment in patients with the mutation whose cancer has spread beyond the lungs. This marks the first companion diagnostic that detects epidermal growth factor receptor (EGFR) gene mutations to be approved by the U.S. Food and Drug Administration, the agency said. The diagnostic is called the Cobas EGFR Mutation Test. ...</p><br clear="all"/>

Source: You are not allowed to view links. Register or Login
You are not allowed to view links. Register or Login